Expert Review of Precision Medicine and Drug Development

Expert Rev Precis Med Drug Dev

2380-8993

Therapeutic Area

Biotechnology, Genomics, Pharmacogenetics & Pharmacogenomics, Pharmacology

Bioengineers, Biomedical Engineers/Technologists, Biomedical Researchers, Clinical Engineers, Clinical Pharmacologists, Health Scientists, Industrial Scientists, Pharmacologists, Scientists

Expert Review of Precision Medicine and Drug Development [e-ISSN 2380-8993] is an international journal publishing rigorously peer-reviewed review articles and original papers on the development and clinical application of medicine to be used in a personalised therapy setting. In an era where medicine is recognizing that a one-size-fits-all approach is not always appropriate, Expert Review of Precision Medicine and Drug Development supports the necessity to identify patients responsive to treatments and treat patient populations using a tailored approach. Articles focus on the following key areas: Development and application of drugs targeted to specific genotypes and populations, as well as advanced diagnostic technologies and significant biomarkers that aid in this; Clinical trials and case studies within personalised therapy and drug development; Screening, prediction and prevention of disease, prediction of adverse events, treatment monitoring, effects of metabolomics and microbiomics on treatment; Secondary population research, genome-wide association studies, disease–gene association studies, personal genome technologies; Ethical and cost–benefit issues, the impact to healthcare and business infrastructure, and regulatory issues. Comprehensive coverage in each review is complemented by the unique Expert Collection format and includes the following sections: Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results; Article Highlights – an executive summary of the author’s most critical points.

No associations affiliated with this journal

Taylor & Francis, Inc. - UK

Electronic Circulation Submission to Acceptance Acceptance to Online Publication Rejection Rate Frequency Author Submission Guidelines